Recombinant shingles vaccine linked to lower dementia risk, especially in women

Study published in Nature Medicine found that the recombinant shingles vaccine is linked to a reduced risk of dementia. This protective effect was particularly notable in females, suggesting a potential advantage of the recombinant vaccine over the live vaccine.

Takeda’s FRUZAQLA gains approval in Japan for colorectal cancer

FRUZAQLA is intended for patients with CRC that has progressed following chemotherapy. Credit: SewCreamStudio/Shutterstock. Takeda has secured approval from the Japanese Ministry of Health, Labour

September 24, 2024

Socially Determined and Uber Health Partner to Bridge Healthcare and Social Needs

What You Should Know: – Socially Determined, the leading social risk analytics company, and Uber Health, the healthcare platform for seamless benefit coordination, have announced

January 9, 2024

Aadi says its solid tumor drug is unlikely to succeed, winding down the trial and axing staffers

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.